Erythematous Facial Rash

Marjorie E. Montanez-Wiscovich, MD, PhD
Akshitha Thatiparthi, DO

American Family Physician. 2026;114(5):539-540.

Author Disclosure: Dr. Montanez-Wiscovich disclosed a relationship with Incyte as a researcher for atopic dermatitis. All relevant financial relationships have been mitigated. All other individuals in a position to control content for this activity have indicated they have no relevant financial relationships to disclose.

A 68-year-old woman presented for evaluation of a pruritic, burning rash around her mouth and nose that first developed 4 years earlier. She had severe flare-ups approximately every 2 weeks but no worsening of symptoms following exposure to sunlight or consumption of alcohol. The rash has been treated with oral antibiotics, and intramuscular and topical corticosteroids with only temporary symptom relief. The patient had applied an over-the-counter mentholated topical ointment around her nose and mouth approximately twice a month for more than 50 years but used no other products on her face. She had no known allergies to cosmetics, personal care products, or synthetic materials.

Physical examination revealed well-defined, pink, scaly plaques with fissures on the central and lower face (Figure 1).

FIGURE 1

QUESTION

Based on the patient's history and physical examination, which one of the following is the most likely diagnosis?

  • A. Allergic contact dermatitis.
  • B. Perioral dermatitis.
  • C. Rosacea.
  • D. Seborrheic dermatitis.
  • E. Tinea faciei.

DISCUSSION

The answer is A: allergic contact dermatitis. The chronicity, well-demarcated eczematous plaques, and fissuring support the diagnosis of allergic contact dermatitis. This was confirmed by a patch test with a positive reaction to turpentine oil.

Allergic contact dermatitis affects approximately 20% of the general population.1 The condition is more common in individuals with occupational exposure to sensitizing agents, including health care professionals, hairdressers, cleaners, industrial workers, and machinists.2 Allergic contact dermatitis is a delayed (type IV) hypersensitivity reaction mediated by allergen-specific T lymphocytes. Sensitization occurs when haptens penetrate the epidermis, bind to proteins, and form complete antigens that are presented by Langerhans cells to T cells.3 Repeated or prolonged exposure may be required before sensitization occurs, as in this case.

Allergic contact dermatitis most commonly presents as pruritic, scaly, erythematous papules and plaques. It may appear vesicular with crusting or bullae. Lichenification is common with chronic allergic contact dermatitis due to repeated inflammation and scratching. Symptoms of acute allergic contact dermatitis typically develop 24 to 72 hours after allergen exposure and reach peak intensity between 48 and 72 hours.3

Epicutaneous patch testing is the standard diagnostic tool for allergic contact dermatitis.4 Primary treatment is avoidance of the allergen. If contact occurs, symptoms should be treated with topical medications such as corticosteroids, calcineurin inhibitors, or phosphodiesterase-4 inhibitors. Systemic therapy such as an interleukin-4 or interleukin-13 inhibitor may be necessary if topical therapy is ineffective.

Perioral dermatitis presents as erythematous papules and pustules centered around the mouth, nose, and sometimes the eyelids. Use of topical corticosteroids often triggers or exacerbates rather than improves symptoms.5

Rosacea also causes persistent centrofacial erythema but often with inflammatory papules or pustules, telangiectasias, and ocular symptoms.6 Common triggers of rosacea symptoms include sunlight, stress, alcohol, and spicy foods.

Seborrheic dermatitis is a chronic papulosquamous condition that develops in sebaceous-rich areas and is associated with Malassezia species. Typical findings include erythematous plaques with greasy, yellow scale often involving the scalp, eyebrows, ears, nasolabial folds, and chest.7

Tinea faciei is caused by a dermatophyte fungal infection and typically presents as erythematous, annular plaques with central clearing and an active, scaly border. Dermatophyte infection usually worsens with topical corticosteroid use due to tinea incognito.8

MARJORIE E. MONTANEZ-WISCOVICH, MD, PhD, is a clinical associate professor in the Department of Dermatology at the University of Florida, Gainesville.

AKSHITHA THATIPARTHI, DO, is a third-year resident in the Department of Dermatology at the University of Florida, Gainesville.

Address correspondence to Marjorie E. Montanez-Wiscovich, MD, PhD, at m.montanez@dermatology.med.ufl.edu.

Author Disclosure: Dr. Montanez-Wiscovich disclosed a relationship with Incyte as a researcher for atopic dermatitis. All relevant financial relationships have been mitigated. All other individuals in a position to control content for this activity have indicated they have no relevant financial relationships to disclose.

  1. 1.Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77-85.
  2. 2.Olusegun OA, Martincigh BS. Allergic contact dermatitis: a significant environmental and occupational skin disease. Int J Dermatol. 2021;60(9):1082-1091.
  3. 3.Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. Pharmacol Res. 2020;162:105282.
  4. 4.Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis. 2015;73(4):195-221.
  5. 5.Searle T, Ali FR, Al-Niaimi F. Perioral dermatitis: diagnosis, proposed etiologies, and management. J Cosmet Dermatol. 2021;20(12):3839-3848.
  6. 6.van Zuuren EJ, Arents BWM, van der Linden MMD, et al. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021;22(4):457-465.
  7. 7.Sowell J, Pena SM, Elewski BE. Seborrheic dermatitis in older adults: pathogenesis and treatment options. Drugs Aging. 2022;39(5):315-321.
  8. 8.Khiewplueang K, Leeyaphan C, Bunyaratavej S, et al. Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand. Mycoses. 2024;67(6):e13754.

The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at https://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. Email submissions to afpphoto@aafp.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of Photo Quiz published in AFP is available at https://www.aafp.org/afp/photoquiz.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.